Serbia

Serbia is one of the fast growing emerging clinical trials markets in Europe. It has many advantages for conducting clinical studies:
  • Clinical trial approval time takes up to 2 months;
  • Rapid enrollment;
  • Significant economic advantages;
  • High site productivity;
  • Significant clinical trial potential in major therapeutic areas;
  • Advanced clinical infrastructure.
Smooth Drug Development provides consulting services in the field of clinical trials to pharmaceutical and biotech companies in Germany, Latvia, Lithuania, Estonia, Hungary, Slovakia, Croatia, Russia, Ukraine and Belarus.